Tfr Capital, Llc. Vertex Pharmaceuticals Inc Transaction History
Tfr Capital, Llc.
- $240 Billion
- Q1 2025
A detailed history of Tfr Capital, Llc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Tfr Capital, Llc. holds 4,756 shares of VRTX stock, worth $2.42 Million. This represents 0.96% of its overall portfolio holdings.
Number of Shares
4,756
Previous 4,561
4.28%
Holding current value
$2.42 Million
Previous $1.84 Billion
25.54%
% of portfolio
0.96%
Previous 0.91%
Shares
2 transactions
Others Institutions Holding VRTX
# of Institutions
1,801Shares Held
224MCall Options Held
1.63MPut Options Held
1.47M-
Capital World Investors Los Angeles, CA28.3MShares$14.4 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$11.9 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.9 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$6.1 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$5.31 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $131B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...